These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6151410)

  • 1. The dependence of excitatory junction potential amplitude on the external calcium concentration in narcotic tolerant mouse vas deferens.
    Einstein R; Lavidis NA
    Br J Pharmacol; 1984 Dec; 83(4):853-61. PubMed ID: 6151410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dependence of excitatory junction potential amplitude on the external calcium concentration in mouse vas deferens during narcotic withdrawal.
    Einstein R; Lavidis NA
    Br J Pharmacol; 1984 Dec; 83(4):863-70. PubMed ID: 6151411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electrophysiological analysis of the effects of morphine on the calcium dependence of neuromuscular transmission in the mouse vas deferens.
    Bennett MR; Lavidis NA
    Br J Pharmacol; 1980 Jun; 69(2):185-91. PubMed ID: 6254588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens.
    Illes P; Zieglgänsberger W; Herz A
    Brain Res; 1980 Jun; 191(2):511-22. PubMed ID: 6247017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of morphine on the neuro-effector transmission in the guinea-pig ileum and in the mouse vas deferens.
    Ito Y; Tajima K
    J Physiol; 1980 Oct; 307():367-83. PubMed ID: 6259338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression by morphine of excitatory junction potentials in the vas deferens of the mouse.
    Henderson G; North RA
    Br J Pharmacol; 1976 Jul; 57(3):341-6. PubMed ID: 974315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens.
    Karunanithi S; Lavidis NA
    Br J Pharmacol; 2001 Jan; 132(2):403-10. PubMed ID: 11159688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium ions, morphine tolerance and noradrenergic transmission in the mouse vas deferens.
    Marshall I; Phillips DG; Nasmyth PA
    Eur J Pharmacol; 1981 Nov; 75(4):205-13. PubMed ID: 6274667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens.
    North RA; Vitek LV
    Br J Pharmacol; 1980 Mar; 68(3):399-405. PubMed ID: 7052335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An electrophysiological analysis of the effects of amine-uptake blockers and alpha-adrenoceptor blockers on adrenergic neuromuscular transmission.
    Bennett MR; Middleton J
    Br J Pharmacol; 1975 Sep; 55(1):87-95. PubMed ID: 241445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of divalent cations and normorphine on spontaneous excitatory junction potentials in the mouse vas deferens.
    Illes P; North RA
    Br J Pharmacol; 1982 Apr; 75(4):599-604. PubMed ID: 7066607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone elicits an excitatory response in the morphine-tolerant mouse vas deferens.
    Vargas ML; Musacchio JM; Bansinath M; Turndorf H; Puig MM
    Neuropharmacology; 1987 Dec; 26(12):1815-8. PubMed ID: 3437943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic morphine treatment on transmitter release from sympathetic varicosities of the mouse vas deferens.
    Lavidis NA
    Br J Pharmacol; 1995 Dec; 116(7):2860-5. PubMed ID: 8680717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions among the effects of normorphine, calcium and magnesium on transmitter release in the mouse vas deferens.
    Milner JD; North RA; Vitek LV
    Br J Pharmacol; 1982 May; 76(1):45-9. PubMed ID: 6123358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electrophysiological analysis of the actions of prostaglandin on neuromuscular transmission in the guinea-pig vas deferens.
    Ito Y; Tajima K
    J Physiol; 1979 Dec; 297(0):521-37. PubMed ID: 231652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice.
    Illes P; Schulz R
    Br J Pharmacol; 1980; 71(1):195-200. PubMed ID: 6258687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium channel antagonists on action potential conduction and transmitter release in the guinea-pig vas deferens.
    Beattie DT; Cunnane TC; Muir TC
    Br J Pharmacol; 1986 Sep; 89(1):235-44. PubMed ID: 2879591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of morphine on the nerve terminal impulse and transmitter release from sympathetic varicosities innervating the mouse vas deferens.
    Lavidis NA
    Br J Pharmacol; 1995 Dec; 116(7):2852-9. PubMed ID: 8680716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of mouse vas deferens to neurotransmitters: changes after morphine treatment.
    Contreras E; Martí MC
    Br J Pharmacol; 1979 Apr; 65(4):623-8. PubMed ID: 35263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of opiates on the terminal nerve impulse and quantal secretion from visualized amphibian nerve terminals.
    Lavidis NA
    Br J Pharmacol; 1995 Jun; 115(3):441-50. PubMed ID: 7582455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.